India's Glenmark to study potential COVID-19 drug combination

Glenmark Pharmaceuticals Ltd said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, ... Read more

Bron:

Reuters: Health News